These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The clinical efficacy and safety of intravenous levofloxacin in the treatment of 4888 patients with bacterial infections: a multi-center trial]. Cooperation Group for Phase IV Clinical Study of Levofloxacin Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):492-6. PubMed ID: 19954047 [TBL] [Abstract][Full Text] [Related]
5. Commentary on "Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis" by Ambrose et al. Gwaltney JM Diagn Microbiol Infect Dis; 2008 May; 61(1):21-2. PubMed ID: 18375085 [No Abstract] [Full Text] [Related]
7. Re: treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen. Olapade-Olaopa EO; Adebayo SA J Urol; 2006 Jun; 175(6):2365-6; author reply 2366. PubMed ID: 16697876 [No Abstract] [Full Text] [Related]
8. Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia. Rahman MM; Khan MA Bangladesh Med Res Counc Bull; 2009 Dec; 35(3):91-4. PubMed ID: 20922911 [TBL] [Abstract][Full Text] [Related]
9. [Clinical positioning of levofloxacin in the treatment of nosocomial pneumonia]. Beloborodov VB Antibiot Khimioter; 2008; 53(9-10):12-20. PubMed ID: 19441645 [No Abstract] [Full Text] [Related]
10. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)]. Scheen AJ Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704 [TBL] [Abstract][Full Text] [Related]
11. [Levofloxacin in complex therapy of patients with skin and soft tissue infections]. Blatun LA; Terekhova RP Antibiot Khimioter; 2008; 53(9-10):32-5. PubMed ID: 19441647 [No Abstract] [Full Text] [Related]
12. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen. Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609 [TBL] [Abstract][Full Text] [Related]
14. [Use of levofloxacin in the hospital]. Castells X; Vallano A; Campany D; Rigau D; Arnau JM Rev Esp Quimioter; 2003 Jun; 16(2):221-6. PubMed ID: 12973461 [TBL] [Abstract][Full Text] [Related]
15. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media. Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154 [TBL] [Abstract][Full Text] [Related]
16. [Present aspects and prospects of levofloxacin use in therapy of nosocomial pneumonia]. Riabkova EL; Kozlov RS Antibiot Khimioter; 2008; 53(9-10):6-11. PubMed ID: 19441644 [No Abstract] [Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia. Benko R; Matuz M; Doro P; Peto Z; Molnar A; Hajdu E; Nagy E; Gardi J; Soos G Int J Antimicrob Agents; 2007 Aug; 30(2):162-8. PubMed ID: 17570646 [TBL] [Abstract][Full Text] [Related]
18. Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval. Lode H; Eller J; Linnhoff A; Ioanas M; Eur Respir J; 2004 Dec; 24(6):947-53. PubMed ID: 15572537 [TBL] [Abstract][Full Text] [Related]